“Periodontal Disease and Heart Disease: What the Research Actually Shows”

Your mouth and your heart are connected in ways that medicine is still working to fully understand. The idea that gum disease might influence heart disease has been debated for over three decades, generating hundreds of studies and more than a few headlines.

The relationship is real. But it is also more complicated than “gum disease causes heart attacks.” Let’s walk through what the evidence actually shows, where the gaps remain, and what this means for how you take care of yourself.

The Epidemiological Evidence: What Large Studies Tell Us

The connection between periodontal disease and cardiovascular disease first gained serious attention in 1989, when a Finnish study of over 1,000 men found that dental infections were associated with increased risk of coronary heart disease events, even after adjusting for known risk factors [5].

Since then, multiple large prospective studies and meta-analyses have confirmed the association:

• A meta-analysis of 7 cohort studies (involving over 100,000 participants) found that individuals with periodontitis had a 1.14 to 1.59 times higher risk of developing coronary heart disease compared to controls [1].
• The ARIC (Atherosclerosis Risk in Communities) study, following over 6,000 people, found that periodontal disease was independently associated with increased carotid artery intima-media thickness, an early marker of atherosclerosis [6].
• A Swedish study of 1,676 participants followed for 26 years found that individuals who were missing teeth (a marker of past severe periodontal disease) had a significantly higher incidence of cardiovascular events [7].

In 2012, the American Heart Association published a scientific statement reviewing the full body of evidence. Their conclusion: an association exists between periodontal disease and atherosclerotic vascular disease, but the evidence does not yet prove that periodontitis directly causes cardiovascular events [8]. That distinction matters, and we will come back to it.

How Might Gum Disease Affect the Heart? Three Proposed Mechanisms

Researchers have identified three primary pathways through which periodontal disease could influence cardiovascular health.

1. Direct Bacterial Invasion

Your periodontal pockets are teeming with bacteria. In a person with moderate to severe periodontitis, the total surface area of ulcerated pocket epithelium (the raw tissue lining the pockets) can be as large as the palm of your hand [9]. Every time you chew, brush, or even just poke at inflamed gums, bacteria enter your bloodstream. This is called bacteremia, and it happens much more frequently than most people realize.

The bacterium that has attracted the most attention is Porphyromonas gingivalis (P. gingivalis), a keystone pathogen in periodontal disease. Multiple studies have detected P. gingivalis DNA in atherosclerotic plaques removed from patients undergoing carotid endarterectomy and coronary artery bypass surgery [2]. The bacterium has also been found in aneurysm tissue and in thrombi retrieved from stroke patients [10].

P. gingivalis is not just a passive bystander in these plaques. In lab studies, it has been shown to invade endothelial cells (the cells lining blood vessels), promote foam cell formation (an early step in plaque development), and activate platelet aggregation, all of which contribute to atherosclerosis [11].

2. Systemic Inflammation

Periodontal disease is a chronic inflammatory condition. Even when it is painless and seemingly localized to the mouth, it produces inflammatory mediators that enter the bloodstream and affect the entire body.

Studies have consistently found that people with periodontitis have elevated levels of:

• C-reactive protein (CRP): A key inflammatory marker that is also an independent predictor of cardiovascular events. Patients with periodontitis have CRP levels 0.5-1.0 mg/L higher than controls on average [3].
• Interleukin-6 (IL-6): A pro-inflammatory cytokine that stimulates CRP production in the liver and plays a role in endothelial dysfunction.
• Fibrinogen: A blood clotting protein that, when elevated, increases the risk of thrombotic events.
• Matrix metalloproteinases (MMPs): Enzymes that break down tissue, contributing to both periodontal tissue destruction and the instability of atherosclerotic plaques.

This chronic, low-grade systemic inflammation is thought to accelerate the development and progression of atherosclerosis. The endothelial cells lining your blood vessels are sensitive to inflammatory signals. Chronic exposure to elevated CRP and IL-6 makes them more permeable to LDL cholesterol, more likely to express adhesion molecules that attract immune cells, and more prone to dysfunction [12].

3. Immune Cross-Reactivity

A third proposed mechanism involves molecular mimicry. Certain proteins on the surface of oral bacteria share structural similarities with proteins in human cardiovascular tissue. The immune system, activated by these bacterial proteins, may generate antibodies that cross-react with host tissues, damaging blood vessel walls in the process [13].

This mechanism is less well-established than the first two but remains an active area of research.

The Shared Risk Factor Problem

Here is where the story gets complicated. Periodontal disease and cardiovascular disease share many of the same risk factors:

• Smoking: The number one modifiable risk factor for both conditions. Smokers are 2-3 times more likely to develop severe periodontitis and have significantly higher cardiovascular risk [14].
• Diabetes: Increases the risk and severity of both conditions through impaired immune function, increased inflammation, and vascular damage [15].
• Obesity: Associated with both periodontal disease and cardiovascular disease, partly through systemic inflammation.
• Age: Both conditions become more prevalent with age.
• Socioeconomic status: Lower income and education levels are associated with both poorer oral health and higher cardiovascular risk.

This overlap makes it genuinely difficult to determine whether periodontal disease independently causes cardiovascular problems or whether both diseases simply result from the same underlying risk factors. This is the central challenge that researchers continue to grapple with.

Most well-designed studies attempt to adjust for these shared risk factors, and the association between periodontitis and cardiovascular disease generally persists after adjustment. But residual confounding (unmeasured or imperfectly measured confounding variables) can never be entirely eliminated in observational studies.

Does Treating Gum Disease Reduce Heart Risk?

This is the question everyone wants answered. If periodontal disease truly contributes to cardiovascular disease, then treating it should reduce cardiovascular risk. So what does the evidence show?

The Inflammation Connection

Multiple studies have demonstrated that periodontal treatment (specifically scaling and root planing) reduces systemic inflammatory markers. A meta-analysis of 25 intervention studies found that periodontal treatment reduced CRP levels by an average of 0.50 mg/L and improved flow-mediated dilation (a measure of endothelial function) [4]. These are meaningful changes from a cardiovascular risk perspective.

The Missing Piece: Hard Endpoints

What we do not yet have is a large randomized controlled trial showing that treating periodontal disease reduces the rate of heart attacks and strokes. Such a trial would be enormously expensive, would need to follow thousands of patients for years, and faces ethical challenges (you cannot randomly assign people to not receive periodontal treatment).

The closest we have come is the PAVE (Periodontitis and Vascular Events) pilot study, which enrolled 303 patients with both periodontal disease and a history of cardiovascular events. Participants were randomized to receive either intensive periodontal treatment or community-based dental care. The study was designed primarily to test feasibility, and while there were trends toward reduced cardiovascular events in the treatment group, the trial was too small and too short to reach statistical significance [16].

Several larger trials are ongoing or have been proposed. Until their results are available, the question of whether periodontal treatment directly prevents cardiovascular events remains formally unanswered.

What the American Heart Association Says

The AHA’s 2012 scientific statement [8] remains the most authoritative synthesis of the evidence. Their key conclusions:

1. Observational studies support an association between periodontal disease and atherosclerotic vascular disease, independent of known confounders.
2. The evidence does not support a causal relationship at this time.
3. Periodontal treatment reduces systemic inflammation, but there is no evidence yet that it prevents cardiovascular events.
4. Statements that imply treating periodontal disease will prevent heart disease or stroke are not supported by current evidence.

It is worth noting that this statement was published in 2012. Since then, the mechanistic evidence has strengthened considerably, particularly regarding P. gingivalis in arterial plaques. But the basic conclusions have not been overturned.

P. gingivalis: The Bacterium That Changed the Conversation

If one organism has driven the periodontal-cardiovascular discussion forward, it is Porphyromonas gingivalis. This gram-negative anaerobe is not just a major player in periodontal disease. It appears to have properties that make it uniquely dangerous outside the mouth.

P. gingivalis produces enzymes called gingipains that can degrade host proteins, disrupt immune responses, and activate inflammatory pathways. In animal models, oral infection with P. gingivalis accelerates atherosclerosis in a dose-dependent manner [17].

A 2019 study that received widespread attention found P. gingivalis gingipains in the brains of Alzheimer’s disease patients, expanding the conversation about this bacterium’s systemic effects well beyond cardiovascular disease [18]. While the Alzheimer’s connection remains preliminary, it underscores the point that oral bacteria do not stay in the mouth.

The practical implication: controlling P. gingivalis through periodontal treatment is important not just for your gums, but potentially for your whole body.

What This Means for You

The relationship between periodontal disease and heart disease may not be definitively proven as causal, but the evidence is strong enough to take seriously. Here is a practical framework:

If You Have Periodontal Disease

Get it treated. Not because doing so is guaranteed to prevent a heart attack, but because: (a) the evidence increasingly suggests it might help, (b) periodontal treatment definitely reduces systemic inflammation, (c) keeping your teeth matters for nutrition and quality of life, and (d) periodontal disease is treatable.

If You Have Cardiovascular Disease

Get a periodontal evaluation. People with existing heart disease should be particularly attentive to their gum health. Chronic periodontal inflammation adds to the systemic inflammatory burden your body is already dealing with. Reducing that burden is a reasonable goal, even without definitive proof of cardiovascular benefit.

If You Have Neither

Prevention is easier than treatment for both conditions. The lifestyle factors that protect your heart (not smoking, maintaining a healthy weight, controlling blood sugar, eating a diet rich in fruits and vegetables, staying active) also protect your gums. And maintaining good oral hygiene is one of the simplest, cheapest health interventions available.

The Bigger Picture: Oral Health as Whole-Body Health

The periodontal-cardiovascular connection is part of a larger shift in how medicine views the relationship between oral health and systemic health. Your mouth is not separate from the rest of your body. It is a gateway, a reservoir of microorganisms, and a source of chronic inflammation that can affect distant organs.

Periodontal disease has been linked not only to cardiovascular disease but also to diabetes complications, adverse pregnancy outcomes, respiratory infections, rheumatoid arthritis, and possibly Alzheimer’s disease [19]. The common thread is inflammation.

Taking care of your gums is not just about keeping your teeth. It is part of taking care of your whole body. The evidence for the oral-systemic connection has become too strong to ignore, even if all the mechanistic details have not been worked out yet.

As a patient, you do not need to wait for a perfect randomized controlled trial to act on this information. The downside of treating gum disease is minimal (healthier gums, fresher breath, keeping your teeth). The potential upside, if the cardiovascular connection proves causal, is significant. That is a bet worth making.

References

1. Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J. 2007;154(5):830-837. doi:10.1016/j.ahj.2007.06.037
2. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000;71(10):1554-1560. doi:10.1902/jop.2000.71.10.1554
3. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008;35(4):277-290. doi:10.1111/j.1600-051X.2007.01173.x
4. Teeuw WJ, Slot DE, Susanto H, et al. Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta-analysis. J Clin Periodontol. 2014;41(1):70-79. doi:10.1111/jcpe.12171
5. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. BMJ. 1989;298(6676):779-781. doi:10.1136/bmj.298.6676.779
6. Beck JD, Elter JR, Heiss G, Couper D, Mauriello SM, Offenbacher S. Relationship of periodontal disease to carotid artery intima-media wall thickness: the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2001;21(11):1816-1822. doi:10.1161/hq1101.097803
7. Holmlund A, Holm G, Lind L. Number of teeth as a predictor of cardiovascular mortality in a cohort of 7,674 subjects followed for 12 years. J Periodontol. 2010;81(6):870-876. doi:10.1902/jop.2010.090680
8. Lockhart PB, Bolger AF, Papapanou PN, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? A scientific statement from the American Heart Association. Circulation. 2012;125(20):2520-2544. doi:10.1161/CIR.0b013e31825719f3
9. Nesse W, Abbas F, van der Ploeg I, Spijkervet FK, Dijkstra PU, Vissink A. Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol. 2008;35(8):668-673. doi:10.1111/j.1600-051X.2008.01249.x
10. Pyysalo MJ, Pyysalo LM, Pessi T, Karhunen PJ, Ohman JE. The connection between ruptured cerebral aneurysms and odontogenic bacteria. J Neurol Neurosurg Psychiatry. 2013;84(11):1214-1218. doi:10.1136/jnnp-2012-304635
11. Hayashi C, Gudber CE, Gibson FC, 3rd, Genco CA. Review: pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol. 2010;25(5):305-316. doi:10.1111/j.2041-1014.2010.00582.x
12. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135-1143. doi:10.1161/hc0902.104353
13. Chukkapalli SS, Rivera MF, Velsko IM, et al. Invasion of oral and aortic tissues by oral spirochete Treponema denticola in ApoE(-/-) mice causally links periodontal disease and atherosclerosis. Infect Immun. 2014;82(5):1959-1967. doi:10.1128/IAI.01511-14
14. Bergstrom J. Tobacco smoking and risk for periodontal disease. J Clin Periodontol. 2003;30(2):107-113. doi:10.1034/j.1600-051x.2003.00272.x
15. Taylor GW, Borgnakke WS. Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis. 2008;14(3):191-203. doi:10.1111/j.1601-0825.2008.01442.x
16. Offenbacher S, Beck JD, Moss K, et al. Results from the Periodontitis and Vascular Events (PAVE) study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol. 2009;80(2):190-201. doi:10.1902/jop.2009.080007
17. Li L, Messas E, Batber EL, Loscalzo J, D’Aiuto F. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation. 2002;105(7):861-867. doi:10.1161/hc0702.104178
18. Dominy SS, Lynch C, Ermini F, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5(1):eaau3333. doi:10.1126/sciadv.aau3333
19. Linden GJ, Lyons A, Scannapieco FA. Periodontal systemic associations: review of the evidence. J Clin Periodontol. 2013;40 Suppl 14:S8-S19. doi:10.1111/jcpe.12064

Related Reading

• Gum Disease Symptoms: Early Warning Signs You Should Not Ignore
• Periodontal Disease Treatment: From Deep Cleaning to Regenerative Options
• Gum Disease Treatment at Home: What Works and What Does Not
• Understanding Chronic Inflammation
• Heart Health and Regenerative Medicine